MOESM1 of Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

Muñoz-Galván, Sandra; Felipe-Abrio, Blanca; Verdugo-Sivianes, Eva M.; Perez, Marco; Jiménez-García, Manuel; Suarez-Martinez, Elisa; Estevez-Garcia, Purificacion; Carnero, Amancio

doi:10.6084/m9.figshare.11577999.v1

12943_2020_1130_MOESM1_ESM.pdf (80.96 kB)

MOESM1 of Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

journal contribution

posted on 2020-01-12, 04:53 authored by Sandra Muñoz-Galván, Blanca Felipe-Abrio, Eva M. Verdugo-Sivianes, Marco Perez, Manuel Jiménez-García, Elisa Suarez-Martinez, Purificacion Estevez-Garcia, Amancio Carnero

Additional file 1 : Table S1. Reagents used in this work. Table S2. Characteristics of patient public databases used in this study. Table S3. CSC markers in OVCAR8 and SKOV3 ovarian tumor cell lines. Table S4. Patient Cohort characteristics.

Funding

Ministerio de Ciencia, Innovación y Universidades

History

Usage metrics

Keywords

Ovarian cancer MYPT1 (PPP1R12A)miR-30b Therapy resistance Hippo pathway Stemness

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

Funding

Ministerio de Ciencia, Innovación y Universidades

History

Usage metrics

Categories

Keywords

Licence

Exports